NCT04693871

Brief Summary

Radiofrequency ablation of atrial fibrillation combined with left atrial appendage closure can not only improve symptoms in patients with non-valvular atrial fibrillation, but also prevent left atrial appendage thrombosis. The safety and effectiveness of left atrial appendage occlusion have been confirmed by randomized controlled trials and actual experience. Among patients with different left atrial appendage emptying speeds, there are limited studies on the structure and function of the left atrial appendage after LAA closure. In this study, patients with persistent nonvalvular atrial fibrillation were selected for radiofrequency ablation combined with LAA closure. The sinus rhythm was restored after the operation. According to the different emptying speed of the left atrial appendage, they were divided into a high-flow rate group and a low-flow rate group. The differences in the structure and function of the left atrium between the two groups were analyzed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 10, 2020

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 5, 2021

Completed
Last Updated

March 18, 2021

Status Verified

January 1, 2020

Enrollment Period

1 year

First QC Date

December 10, 2020

Last Update Submit

March 17, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes in the structure of the left atrium

    Measure the left atrial transverse diameter, anteroposterior diameter, upper and lower diameter.

    1year

  • Changes in the function of the left atrium

    Left atrium volume. Two-chamber and four-chamber left atrium strain and strain rate, left atrium storage function, channel function and pump function.

    1year

Study Arms (2)

high-flow rate group

Device: Transesophageal ultrasound

low-flow rate group

Device: Transesophageal ultrasound

Interventions

Patients with nonvalvular atrial fibrillation underwent radiofrequency ablation combined with left atrial appendage closure and recovered to sinus rhythm after the operation. To study the changes of left atrial organization and function of two groups of patients with different left atrial appendage emptying speeds.

Also known as: Radiofrequency ablation of atrial fibrillation combined with left atrial appendage closure
high-flow rate grouplow-flow rate group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with non-valvular atrial fibrillation between the ages of 18 and 80 received atrial fibrillation radiofrequency ablation combined with left atrial appendage occlusion, and recovered to sinus rhythm after the operation. According to the different left atrial appendage emptying speed, it is divided into a higher left atrial appendage emptying speed group and a lower left atrial appendage emptying speed group.

You may qualify if:

  • Patients who received atrial fibrillation radiofrequency ablation combined with left atrial appendage closure.
  • Exclude Criteria
  • Patients with incomplete data.
  • Device embolism.
  • Residual shunt around the device found by transesophageal echocardiography greater than 5 mm.
  • Mitral valve stenosis.
  • Artificial valve.
  • Atrial septal defect.
  • Dilated cardiomyopathy
  • Moderate Severe mitral regurgitation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second Hospital of Hebei Medical University

Shijiazhuang, Hebei, 050000, China

Location

MeSH Terms

Interventions

Left Atrial Appendage Closure

Intervention Hierarchy (Ancestors)

Cardiac CatheterizationCatheterizationTherapeuticsInvestigative Techniques

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Department of Cardiology in the Second Hospital of Hebei Medical University

Study Record Dates

First Submitted

December 10, 2020

First Posted

January 5, 2021

Study Start

January 1, 2020

Primary Completion

January 1, 2021

Study Completion

January 1, 2021

Last Updated

March 18, 2021

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations